Myriad Genetics, Inc.

Healthcare

NASDAQ:MYGN · NASDAQ Global Select

Market Cap $428.79M Beta 1.64 P/E (TTM) -1.1

$4.54 +3.20%

+$0.14 today

52W Low $3.53High $8.59

Vol 2.44M · Avg 1.81M

EPS (TTM) -$4.27Medical - Diagnostics & Research

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-6.58%

Period High

$8.18

Period Low

$3.55

Latest

$4.54

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Vir Biotechnology, Inc.

NASDAQ:VIR

$1.54B

CareDx, Inc

NASDAQ:CDNA

$1.30B

AMN Healthcare Services, Inc.

NYSE:AMN

$1.20B

Personalis, Inc.

NASDAQ:PSNL

$889.53M

Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

$746.52M

Castle Biosciences, Inc.

NASDAQ:CSTL

$621.44M

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

$577.80M

Fulgent Genetics, Inc.

NASDAQ:FLGT

$512.49M

Evolent Health, Inc.

NYSE:EVH

$497.73M

DarioHealth Corp.

NASDAQ:DRIO

$50.74M

What is the latest MYGN filing?

The latest filing shown is 4 dated Jun 12, 2026.

How many recent filings does MYGN have?

Intrinsic Alpha currently shows 20 recent filings for MYGN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.